Literature DB >> 26626261

Considerations in the Diagnosis and Management of Pediatric Patients With Favorable Histology Wilms Tumor Who Present With Only Pulmonary Nodules.

Daniel M Green1.   

Abstract

More than 70% of children with stage IV, favorable histology (FH) Wilms tumor will be relapse-free survivors 16 years after diagnosis. Successful treatment generally includes whole lung radiation therapy and doxorubicin. Such therapy is associated with adverse, long-term effects, including impaired pulmonary function, congestive heart failure, and second malignant neoplasms, especially breast cancer. Cooperative groups have adopted a risk-based approach to the treatment of these patients. It is important to recall the good overall prognosis for this group before recommendations for intensification are made based on preliminary data and in the absence of histological confirmation of persistent malignant disease.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wilms tumor; histology; pulmonary metastases

Mesh:

Year:  2015        PMID: 26626261      PMCID: PMC4755814          DOI: 10.1002/pbc.25840

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  27 in total

1.  Correction to "Congestive heart failure after treatment for Wilms' tumor".

Authors:  Daniel M Green; Yevgeny A Grigoriev; Bin Nan; Janice R Takashima; Pat A Norkool; Giulio J D'Angio; Norman E Breslow
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

2.  The treatment of stages I-IV favorable histology Wilms' tumor.

Authors:  Daniel M Green
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

3.  CT characteristics of lung nodules present at diagnosis of extrapulmonary malignancy in children.

Authors:  Cicero Torres Silva; Joao Guilherme Amaral; Rahim Moineddin; Wendy Doda; Paul S Babyn
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

4.  Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.

Authors:  Daniel M Green; Wei Liu; William H Kutteh; Raymond W Ke; Kyla C Shelton; Charles A Sklar; Wassim Chemaitilly; Ching-Hon Pui; James L Klosky; Sheri L Spunt; Monika L Metzger; DeoKumar Srivastava; Kirsten K Ness; Leslie L Robison; Melissa M Hudson
Journal:  Lancet Oncol       Date:  2014-09-16       Impact factor: 41.316

5.  Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.

Authors:  M F Tournade; C Com-Nougué; J de Kraker; R Ludwig; A Rey; J M Burgers; B Sandstedt; J Godzinski; M Carli; R Potter; J M Zucker
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

6.  Pulmonary pseudometastases in children with malignant tumors.

Authors:  M Cohen; W L Smith; R Weetman; A Provisor
Journal:  Radiology       Date:  1981-11       Impact factor: 11.105

7.  Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee.

Authors:  J de Kraker; J Lemerle; P A Voûte; J M Zucker; M F Tournade; M Carli
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

8.  Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

Authors:  D M Green; Y A Grigoriev; B Nan; J R Takashima; P A Norkool; G J D'Angio; N E Breslow
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

9.  Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy.

Authors:  Arnauld Verschuur; Harm Van Tinteren; Norbert Graf; Christophe Bergeron; Bengt Sandstedt; Jan de Kraker
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

10.  The role of PET/CT in assessing pulmonary nodules in children with solid malignancies.

Authors:  M Beth McCarville; Catherine Billups; Jianrong Wu; Robert Kaufman; Sue Kaste; Jamie Coleman; Susan Sharp; Helen Nadel; Martin Charron; Henrique Lederman; Steven Don; Stephen Shochat; Najat C Daw; Barry Shulkin
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

View more
  2 in total

1.  Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor.

Authors:  Daniel M Green
Journal:  J Clin Oncol       Date:  2020-01-17       Impact factor: 44.544

2.  Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

Authors:  Conrad V Fernandez; Elizabeth A Mullen; Yueh-Yun Chi; Peter F Ehrlich; Elizabeth J Perlman; John A Kalapurakal; Geetika Khanna; Arnold C Paulino; Thomas E Hamilton; Kenneth W Gow; Zelig Tochner; Fredric A Hoffer; Janice S Withycombe; Robert C Shamberger; Yeonil Kim; James I Geller; James R Anderson; Paul E Grundy; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2017-12-06       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.